Introduction to Infectious Diseases

The growing worldwide resistance to antibiotics requires much more cautious use of antibiotics when treating acute infectious diseases. What can Anthroposophic Medicine contribute in this situation? What possibilities does it offer that go beyond just focusing on the pathogens, how does it therapeutically guide and support a patient’s inflammatory response, and strengthen the person’s immunological resources, both acutely and preventatively? Which procedures have proven successful? How can Anthroposophic Medicine benefit patients with infectious diseases, whether acute or long-term?

In this section we present some of Anthroposophic Medicine’s multi-professional therapeutic concepts for common infectious diseases in childhood and adulthood.

 Fig. «Sick person at night» of Ernst Ludwig Kirchner. © akg-images

Research news

Real World Data Study: Factors Associated with Self-Reported Post/Long-COVID    
Little evidence exists on the risk factors that contribute to Post/Long-COVID (PLC). In a recent prospective study, 99 registered people reported suffering from PLC symptoms - most commonly from fatigue, dyspnea, decreased strenght, hyposmia, and memory loss. The study results show, for example, that people, who suffered from COVID-19-associated anxiety, hyposmia, or palpitations were up to eight times more at risk of developing PLC than people without these symptoms. Individuals who suffered from fatigue during COVID-19 treatment were seven times more at risk to develop PLC fatigue than those who did not show this symptom. Overall, the results revealed that 13% of the study participants who had previously suffered from COVID-19 subsequently reported having PLC. The article is published open access:

Further information on Anthroposophic Medicine